Catalyst Wire Dossier Catalyst Wire Dossier

Novel treatment combination therapies

· Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Novel treatment combination therapies, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01 [Phase 2]

See pricing